Literature DB >> 16505999

Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics.

L J Garey1, K A Von Bussmann, S R Hirsch.   

Abstract

We utilised postmortem brain tissue to quantify sections of left and right orbitofrontal cortex (area 11) from nine schizophrenic and eight control patients from the Charing Cross Prospective Schizophrenia Study immunostained for the presence of the kainate receptor (GluR5/6/7). The numerical density of neurons immunopositive for kainate receptor was measured. Other sections from the same blocks were stained with cresyl violet to determine the total neuronal numerical density. All measurements were made blind: diagnoses were only revealed by a third party after measurements were completed. There was a significant reduction (21%) in numerical density of kainate receptor-positive neurons in both cortices in the schizophrenic group (488 cells/mm2) compared to that in the control group (618 cells/mm2) (P=0.033). Nissl-stained tissue showed no significant difference in total neuronal numerical density between control and schizophrenic groups. These observations suggest that there are actually fewer kainate receptor-positive neurons in schizophrenic orbitofrontal cortex. There was no correlation of reduced kainate receptor-positive cell number with age at death, postmortem interval, or other possibly confounding neuropathology. Our results support the concept of there being reduced glutamatergic activity in frontal cortex in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505999     DOI: 10.1007/s00221-006-0396-8

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  60 in total

1.  Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.

Authors:  P J Harrison; D McLaughlin; R W Kerwin
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

2.  Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

Authors:  M Toru; S Watanabe; H Shibuya; T Nishikawa; K Noda; H Mitsushio; H Ichikawa; A Kurumaji; M Takashima; N Mataga
Journal:  Acta Psychiatr Scand       Date:  1988-08       Impact factor: 6.392

3.  Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia.

Authors:  R H Porter; S L Eastwood; P J Harrison
Journal:  Brain Res       Date:  1997-03-21       Impact factor: 3.252

4.  Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics.

Authors:  K Radewicz; L J Garey; S M Gentleman; R Reynolds
Journal:  J Neuropathol Exp Neurol       Date:  2000-02       Impact factor: 3.685

Review 5.  Anxiety as a paradigm case of emotion.

Authors:  J A Gray
Journal:  Br Med Bull       Date:  1981-05       Impact factor: 4.291

6.  [Long-term chlorpromazine therapy in animal experiments].

Authors:  H Sommer; J Quandt
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1970-09

7.  Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease.

Authors:  T J Crow; J Ball; S R Bloom; R Brown; C J Bruton; N Colter; C D Frith; E C Johnstone; D G Owens; G W Roberts
Journal:  Arch Gen Psychiatry       Date:  1989-12

8.  Distribution of glutamate receptor subunit GluR1 and GABA in human cerebral neocortex: a double immunolabelling and electron microscopic study.

Authors:  Y He; W Y Ong; S K Leong; L J Garey
Journal:  Exp Brain Res       Date:  1996-11       Impact factor: 1.972

9.  The effects of lateralized frontal lesions on mood regulation.

Authors:  J Grafman; S C Vance; H Weingartner; A M Salazar; D Amin
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

10.  Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem.

Authors:  R Kerwin; S Patel; B Meldrum
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

View more
  12 in total

1.  Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.

Authors:  L V Kristiansen; B Bakir; V Haroutunian; J H Meador-Woodruff
Journal:  Schizophr Res       Date:  2010-03-29       Impact factor: 4.939

2.  Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function.

Authors:  Gary E Duncan; Beverly H Koller; Sheryl S Moy
Journal:  Brain Res       Date:  2012-01-20       Impact factor: 3.252

3.  Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia.

Authors:  María D Rubio; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Biol Psychiatry       Date:  2012-03-27       Impact factor: 13.382

Review 4.  When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits.

Authors:  Laurence Garey
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

5.  Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Chang-Gyu Hahn; Neil M Richtand; Kevin E Stanford
Journal:  Schizophr Res       Date:  2007-01-19       Impact factor: 4.939

6.  Ultrarare Loss-of-Function Mutations in the Genes Encoding the Ionotropic Glutamate Receptors of Kainate Subtypes Associated with Schizophrenia Disrupt the Interaction with PSD95.

Authors:  Tsung-Ming Hu; Chia-Liang Wu; Shih-Hsin Hsu; Hsin-Yao Tsai; Fu-Yu Cheng; Min-Chih Cheng
Journal:  J Pers Med       Date:  2022-05-12

7.  Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.

Authors:  Gary E Duncan; Ken Inada; Beverly H Koller; Sheryl S Moy
Journal:  Brain Res       Date:  2009-10-22       Impact factor: 3.252

8.  Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder.

Authors:  Tsung-Ung W Woo; Kevin Shrestha; Christopher Amstrong; Martin M Minns; John P Walsh; Francine M Benes
Journal:  Schizophr Res       Date:  2007-08-14       Impact factor: 4.939

Review 9.  Neurogenic actions of atypical antipsychotic drugs and therapeutic implications.

Authors:  Samuel S Newton; Ronald S Duman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  Therapeutic potential of kainate receptors.

Authors:  Carlos Matute
Journal:  CNS Neurosci Ther       Date:  2010-12-06       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.